Andrew Bowser

Andrew Bowser is a medical writer based in Brooklyn, New York.


Pembro shows promising antitumor activity

August 21, 2019

Pembrolizumab (Keytruda) is showing encouraging antitumor activity in an ongoing phase II study including patients with high-risk, nonmuscle-invasive bladder cancer that is unresponsive to bacillus Calmette-Guérin treatment.

Pyruvate kinase appears to be bladder cancer marker

May 28, 2019

Pyruvate kinase, a primary driver of tumor glycolysis, is promising both as a biomarker of bladder cancer and as a drug target, researchers reported at the 2018 Society of Urologic Oncology annual meeting in Phoenix.

Minimally invasive cystectomy linked with shorter hospital stay

March 25, 2019

Compared to an open approach, minimally invasive radical cystectomy was associated with a near 2-day shorter hospital stay in bladder cancer patients treated at diverse institutions across the United States, according to authors of a recent retrospective analysis of Medicare claims.